EUVIMEDEUVIMED entdecken
Crossref

FOXM1, a super enhancer-associated gene, is related to poorer prognosis and gemcitabine resistance in pancreatic cancer

Jian Jiang, Tianci Shen, Dan Chen, Zihao Dai, Xuelong Wang, Qiang Meng, Zhuo Yang, Di Zhang, Xiaoyi Guo, Jianqiang Xu, Jiangning Gu, Changmiao Wang

Cell Biochemistry and Biophysics · 2025

DOI: 10.1007/s12013-024-01653-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Biochemistry and Biophysics, 2025. Verfasst von Jian Jiang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, the First Affiliated Hospital of Dalian Medical University, Dalian, China. Hauptthemen laut MEDLINE: Deoxycytidine, Pancreatic Neoplasms, Drug Resistance, Neoplasm, Forkhead Box Protein M1. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: the National Nature Science Foundation of China, the General Project of Natural Science Foundation of Liaoning Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DeoxycytidinePancreatic NeoplasmsDrug Resistance, NeoplasmForkhead Box Protein M1Carcinoma, Pancreatic DuctalEnhancer Elements, GeneticHumansGemcitabineCell Line, TumorPrognosisTranscription FactorsAnimalsTriazolesFemaleMiceAzepinesMaleCell Cycle ProteinsAntimetabolites, AntineoplasticGene Expression Regulation, NeoplasticMice, NudeSignal TransductionTransforming Growth Factor betaSuper EnhancersBromodomain Containing Proteins

Stichwörter der Autor:innen

Drug ResistanceFOXM1JQ1Pancreatic cancerSuper enhancer

Substanzen

DeoxycytidineGemcitabineForkhead Box Protein M1(+)-JQ1 compoundTranscription FactorsTriazolesFOXM1 protein, humanAzepinesCell Cycle ProteinsBRD4 protein, human

Autor:innen und Institutionen

  • Department of General Surgery, the First Affiliated Hospital of Dalian Medical University, Dalian, China.
  • Department of Hepatobiliary Surgery, the First Affiliated Hospital of Dalian Medical University, Dalian, China.
  • Department of Pathology, the First Affiliated Hospital of Dalian Medical University, Dalian, China.
  • Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, China.
  • Department of Endoscope, General Hospital of Northern Theater Command, Shenyang, China.
  • School of Life and Pharmaceutical Sciences (LPS) & Panjin Institute of Industrial Technology (PIIT), Dalian University of Technology, Panjin, Liaoning, China.

Förderung

  • the National Nature Science Foundation of China
  • the General Project of Natural Science Foundation of Liaoning Province

Zitieren

APA

Jiang, J., Shen, T., Chen, D., Dai, Z., Wang, X., Meng, Q., Yang, Z., Zhang, D., Guo, X., Xu, J., Gu, J., & Wang, C. (2025). FOXM1, a super enhancer-associated gene, is related to poorer prognosis and gemcitabine resistance in pancreatic cancer. Cell Biochemistry and Biophysics. https://doi.org/10.1007/s12013-024-01653-7

Vancouver

Jiang J, Shen T, Chen D, Dai Z, Wang X, Meng Q, et al. FOXM1, a super enhancer-associated gene, is related to poorer prognosis and gemcitabine resistance in pancreatic cancer. Cell Biochemistry and Biophysics. 2025. doi:10.1007/s12013-024-01653-7

BibTeX
@article{Jiang2025,
  author = {Jiang, Jian and Shen, Tianci and Chen, Dan and Dai, Zihao and Wang, Xuelong and Meng, Qiang and Yang, Zhuo and Zhang, Di and Guo, Xiaoyi and Xu, Jianqiang and Gu, Jiangning and Wang, Changmiao},
  title = {FOXM1, a super enhancer-associated gene, is related to poorer prognosis and gemcitabine resistance in pancreatic cancer},
  journal = {Cell Biochemistry and Biophysics},
  year = {2025},
  doi = {10.1007/s12013-024-01653-7}
}
Kostenlos starten →